ACS Research News
Filtering by:
Immunotherapy
New Treatment for Neuroblastoma Is in Early-Stage Trials
Published on: September 15, 2020
American Cancer Society grantee Andras Heczey, MD, is trying to adapt the technique known as CAR T-cell therapy to cure children with neuroblastoma by using natural killer T cells. He's trying the treatment for the first time in children in a phase 1 clinical trial.
Could Infections Teach Us How to Make Treatments for Pediatric ALL Even Better?
Published on: October 4, 2017
Alix Seif, MD, MPH, is studying a new type of immunotherapy that could teach the immune system long-term memory. The goal is for the immune system to kill any new leukemia cells for the rest of the child's life.
Adapting CAR T-Cell Therapy to Treat Neuroblastoma
Published on: September 25, 2017
With the success of the new drug, Kymriah, pediatric oncology researchers are trying to adapt CAR T-cell therapy to treat solid tumors, like neuroblastoma.
The Current and Future Promise of Immunotherapy for Childhood Cancers
Published on: September 14, 2017
Immunotherapy offers hope to children with cancer who don't respond to standard treatments. The new drug, Kymriah, is likely only the first to use CAR T-cell therapy, which helps immune cells identify cancer cells and kill them.
